论文部分内容阅读
Osiris公司宣布已完成多能成体干细胞新药Provacel~(TM)治疗心脏疾病的临床试验的病例入选,该试验目的在于评估Provacel~(TM)的安全性与初步疗效,Provacel~(TM)为成体干细胞的组成成分,可用于修复被损害的心脏。更为突出的是,Osiris公司的成体干细胞产品不要求特别配型。(贺立?
Osiris Inc. announced that it has completed a clinical trial of pluripotential adult stem cell drug Provacel ™ for the treatment of heart disease. The purpose of this trial was to evaluate the safety and efficacy of Provacel ™ (TM) for adult stem cells The ingredients can be used to repair the damaged heart. More importantly, Osiris’s adult stem cell products do not require special formulations. (He Li?